Bharat Biotech Intranasal Covid Vaccine
<p>
<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/J-uenNwVczU" title="YouTube video player" width="560"></iframe></p>
<p>
With Drugs Controller General of India&rsquo;s (DCGI) green light, Bharat Biotech receives approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin. Trials will be conducted at 9 locations across the country. Watch to know more!</p>
On the 4th death anniversary of human rights activist Karima Baloch, the Baloch Yakjehti Committee…
External Affairs Minister S Jaishankar will visit the US from December 24-29 to discuss key…
Students at the Bolan Medical College (BMC) in Balochistan's Quetta entered the 27th day of…
The intensifying cutting of trees for firewood in Pakistan-occupied Gilgit-Baltistan (PoGB) is not only worsening…
A group of retired judges, bureaucrats, Army officials and other civil society members have penned…
Israel and Slovakia signed a 2 billion shekel (USD 582 million) agreement on Monday to…